Vitamin E (300 mg) in the treatment of MASH: A multi-center, randomized, double-blind, placebo-controlled studyYu Song, Junping Shi, Xiaotang Fan et al.|Cell Reports Medicine|2025Cited by 29
LBP-045 Efficacy and safety of HSK31679, a thyroid hormone receptor β agonist, for the treatment of asian non-alcoholic fatty liver disease: a multicenter randomized, double-blind, placebo-controlled, phase 2a trialXue Feng, Lai Wei, Wei Ma et al.|Journal of Hepatology|2024Cited by 27
Efficacy and Safety of HSK31679 in Asian Patients With MASLD: A Randomized Controlled TrialFeng Xue, Lai Wei, Wei Ma et al.|Clinical Gastroenterology and Hepatology|2025Cited by 2
Low Dose Vitamin E Versus Placebo in the Treatment of Nonalcoholic Steatohepatitis: A Double-Blind, Randomized, Placebo-Controlled Investigator-Initiated TrialYu Song, Junping Shi, Ming‐Hua Zheng et al.|SSRN Electronic Journal|2023Cited by 0
Vitamin E (300mg) Versus Placebo in the Treatment of Nonalcoholic Steatohepatitis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled StudyYu Song, Junping Shi, Ming‐Hua Zheng et al.|SSRN Electronic Journal|2024Cited by 0